Cargando…

Postoperative morbidity and health-related quality of life in children with delayed reconstruction of esophageal atresia: a nationwide Swedish study

BACKGROUND: In 10–15% of children with esophageal atresia (EA) delayed reconstruction of esophageal atresia (DREA) is necessary due to long-gap EA and/or prematurity/low birth weight. They represent a patient subgroup with high risk of complications. We aimed to evaluate postoperative morbidity and...

Descripción completa

Detalles Bibliográficos
Autores principales: Dellenmark-Blom, Michaela, Örnö Ax, Sofie, Öst, Elin, Svensson, Jan F., Kassa, Ann-Marie, Jönsson, Linus, Abrahamsson, Kate, Gatzinsky, Vladimir, Stenström, Pernilla, Tollne, AnnaMaria, Omling, Erik, Engstrand Lilja, Helene
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9207832/
https://www.ncbi.nlm.nih.gov/pubmed/35725462
http://dx.doi.org/10.1186/s13023-022-02381-y
_version_ 1784729609469689856
author Dellenmark-Blom, Michaela
Örnö Ax, Sofie
Öst, Elin
Svensson, Jan F.
Kassa, Ann-Marie
Jönsson, Linus
Abrahamsson, Kate
Gatzinsky, Vladimir
Stenström, Pernilla
Tollne, AnnaMaria
Omling, Erik
Engstrand Lilja, Helene
author_facet Dellenmark-Blom, Michaela
Örnö Ax, Sofie
Öst, Elin
Svensson, Jan F.
Kassa, Ann-Marie
Jönsson, Linus
Abrahamsson, Kate
Gatzinsky, Vladimir
Stenström, Pernilla
Tollne, AnnaMaria
Omling, Erik
Engstrand Lilja, Helene
author_sort Dellenmark-Blom, Michaela
collection PubMed
description BACKGROUND: In 10–15% of children with esophageal atresia (EA) delayed reconstruction of esophageal atresia (DREA) is necessary due to long-gap EA and/or prematurity/low birth weight. They represent a patient subgroup with high risk of complications. We aimed to evaluate postoperative morbidity and health-related quality of life (HRQOL) in a Swedish national cohort of children with DREA. METHODS: Postoperative morbidity, age-specific generic HRQOL (PedsQL(™) 4.0) and condition-specific HRQOL (The EA-QOL questionnaires) in children with DREA were compared with children with EA who had primary anastomosis (PA). Factors associated with the DREA group’s HRQOL scores were analyzed using Mann–Whitney U-test and Spearman’s rho. Clinical data was extracted from the medical records. Significance level was p < 0.05. RESULTS: Thirty-four out of 45 families of children with DREA were included and 30 returned the questionnaires(n = 8 children aged 2–7 years; n = 22 children aged 8–18 years). Compared to children with PA(42 children aged 2–7 years; 64 children aged 8–18 years), there were no significant differences in most early postoperative complications. At follow-up, symptom prevalence in children aged 2–7 with DREA ranged from 37.5% (heartburn) to 75% (cough). Further digestive and respiratory symptoms were present in ≥ 50%. In children aged 8–18, it ranged from 14.3% (vomiting) to 40.9% (cough), with other digestive and airway symptoms present in 19.0–27.3%. Except for chest tightness (2–7 years), there were no significant differences in symptom prevalence between children with DREA and PA, nor between their generic or condition-specific HRQOL scores (p > 0.05). More children with DREA underwent esophageal dilatations (both age groups), gastrostomy feeding (2–7 years), and antireflux treatment (8–18 years), p < 0.05. Days to hospital discharge after EA repair and a number of associated anomalies showed a strong negative correlation with HRQOL scores (2–7 years). Presence of cough, airway infection, swallowing difficulties and heartburn were associated with lower HRQOL scores (8–18 years), p < 0.05. CONCLUSIONS: Although children with DREA need more treatments, they are not a risk group for postoperative morbidity and impaired HRQOL compared with children with PA. However, those with a long initial hospital stay, several associated anomalies and digestive or respiratory symptoms risk worse HRQOL. This is important information for clinical practice, families and patient stakeholders. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13023-022-02381-y.
format Online
Article
Text
id pubmed-9207832
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-92078322022-06-21 Postoperative morbidity and health-related quality of life in children with delayed reconstruction of esophageal atresia: a nationwide Swedish study Dellenmark-Blom, Michaela Örnö Ax, Sofie Öst, Elin Svensson, Jan F. Kassa, Ann-Marie Jönsson, Linus Abrahamsson, Kate Gatzinsky, Vladimir Stenström, Pernilla Tollne, AnnaMaria Omling, Erik Engstrand Lilja, Helene Orphanet J Rare Dis Research BACKGROUND: In 10–15% of children with esophageal atresia (EA) delayed reconstruction of esophageal atresia (DREA) is necessary due to long-gap EA and/or prematurity/low birth weight. They represent a patient subgroup with high risk of complications. We aimed to evaluate postoperative morbidity and health-related quality of life (HRQOL) in a Swedish national cohort of children with DREA. METHODS: Postoperative morbidity, age-specific generic HRQOL (PedsQL(™) 4.0) and condition-specific HRQOL (The EA-QOL questionnaires) in children with DREA were compared with children with EA who had primary anastomosis (PA). Factors associated with the DREA group’s HRQOL scores were analyzed using Mann–Whitney U-test and Spearman’s rho. Clinical data was extracted from the medical records. Significance level was p < 0.05. RESULTS: Thirty-four out of 45 families of children with DREA were included and 30 returned the questionnaires(n = 8 children aged 2–7 years; n = 22 children aged 8–18 years). Compared to children with PA(42 children aged 2–7 years; 64 children aged 8–18 years), there were no significant differences in most early postoperative complications. At follow-up, symptom prevalence in children aged 2–7 with DREA ranged from 37.5% (heartburn) to 75% (cough). Further digestive and respiratory symptoms were present in ≥ 50%. In children aged 8–18, it ranged from 14.3% (vomiting) to 40.9% (cough), with other digestive and airway symptoms present in 19.0–27.3%. Except for chest tightness (2–7 years), there were no significant differences in symptom prevalence between children with DREA and PA, nor between their generic or condition-specific HRQOL scores (p > 0.05). More children with DREA underwent esophageal dilatations (both age groups), gastrostomy feeding (2–7 years), and antireflux treatment (8–18 years), p < 0.05. Days to hospital discharge after EA repair and a number of associated anomalies showed a strong negative correlation with HRQOL scores (2–7 years). Presence of cough, airway infection, swallowing difficulties and heartburn were associated with lower HRQOL scores (8–18 years), p < 0.05. CONCLUSIONS: Although children with DREA need more treatments, they are not a risk group for postoperative morbidity and impaired HRQOL compared with children with PA. However, those with a long initial hospital stay, several associated anomalies and digestive or respiratory symptoms risk worse HRQOL. This is important information for clinical practice, families and patient stakeholders. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13023-022-02381-y. BioMed Central 2022-06-20 /pmc/articles/PMC9207832/ /pubmed/35725462 http://dx.doi.org/10.1186/s13023-022-02381-y Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Dellenmark-Blom, Michaela
Örnö Ax, Sofie
Öst, Elin
Svensson, Jan F.
Kassa, Ann-Marie
Jönsson, Linus
Abrahamsson, Kate
Gatzinsky, Vladimir
Stenström, Pernilla
Tollne, AnnaMaria
Omling, Erik
Engstrand Lilja, Helene
Postoperative morbidity and health-related quality of life in children with delayed reconstruction of esophageal atresia: a nationwide Swedish study
title Postoperative morbidity and health-related quality of life in children with delayed reconstruction of esophageal atresia: a nationwide Swedish study
title_full Postoperative morbidity and health-related quality of life in children with delayed reconstruction of esophageal atresia: a nationwide Swedish study
title_fullStr Postoperative morbidity and health-related quality of life in children with delayed reconstruction of esophageal atresia: a nationwide Swedish study
title_full_unstemmed Postoperative morbidity and health-related quality of life in children with delayed reconstruction of esophageal atresia: a nationwide Swedish study
title_short Postoperative morbidity and health-related quality of life in children with delayed reconstruction of esophageal atresia: a nationwide Swedish study
title_sort postoperative morbidity and health-related quality of life in children with delayed reconstruction of esophageal atresia: a nationwide swedish study
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9207832/
https://www.ncbi.nlm.nih.gov/pubmed/35725462
http://dx.doi.org/10.1186/s13023-022-02381-y
work_keys_str_mv AT dellenmarkblommichaela postoperativemorbidityandhealthrelatedqualityoflifeinchildrenwithdelayedreconstructionofesophagealatresiaanationwideswedishstudy
AT ornoaxsofie postoperativemorbidityandhealthrelatedqualityoflifeinchildrenwithdelayedreconstructionofesophagealatresiaanationwideswedishstudy
AT ostelin postoperativemorbidityandhealthrelatedqualityoflifeinchildrenwithdelayedreconstructionofesophagealatresiaanationwideswedishstudy
AT svenssonjanf postoperativemorbidityandhealthrelatedqualityoflifeinchildrenwithdelayedreconstructionofesophagealatresiaanationwideswedishstudy
AT kassaannmarie postoperativemorbidityandhealthrelatedqualityoflifeinchildrenwithdelayedreconstructionofesophagealatresiaanationwideswedishstudy
AT jonssonlinus postoperativemorbidityandhealthrelatedqualityoflifeinchildrenwithdelayedreconstructionofesophagealatresiaanationwideswedishstudy
AT abrahamssonkate postoperativemorbidityandhealthrelatedqualityoflifeinchildrenwithdelayedreconstructionofesophagealatresiaanationwideswedishstudy
AT gatzinskyvladimir postoperativemorbidityandhealthrelatedqualityoflifeinchildrenwithdelayedreconstructionofesophagealatresiaanationwideswedishstudy
AT stenstrompernilla postoperativemorbidityandhealthrelatedqualityoflifeinchildrenwithdelayedreconstructionofesophagealatresiaanationwideswedishstudy
AT tollneannamaria postoperativemorbidityandhealthrelatedqualityoflifeinchildrenwithdelayedreconstructionofesophagealatresiaanationwideswedishstudy
AT omlingerik postoperativemorbidityandhealthrelatedqualityoflifeinchildrenwithdelayedreconstructionofesophagealatresiaanationwideswedishstudy
AT engstrandliljahelene postoperativemorbidityandhealthrelatedqualityoflifeinchildrenwithdelayedreconstructionofesophagealatresiaanationwideswedishstudy